MARKET
IPO

RZRA

Rezera Inc.
RZRA
NASDAQ
Upcoming IPOs
Expected Listing Date: 2026-11-12
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-
-
-
228.54M~270.10M
-
2026-11-05
Public Filing
View Prospectus
Pending
Offering
Price Range: 11.00~13.00
Shares to be Issued: 16.67M
2026-11-11
Offering End Date
Offering Price: Pending
Post IPO Outstanding: 20.78M
2026-11-12
Listed
U.S. IPO Weekly Recap: Community Bank Debuts Amid Market Fears
Seeking Alpha · 16m ago
About RZRA
Rezera Inc. is formerly known as Nodthera Inc., is a United States-based Company. The Company is a clinical-stage biotechnology company engaged in the discovery and development of oral NLRP3 inhibitors for the treatment of chronic inflammation associated with cardiovascular and neurologic diseases. Its research focuses on reducing inflammation at its source by inhibiting NLRP3 activity while preserving the body's ability to respond to infection. The Company's development programs target inflammation-driven disease pathways affecting blood vessels, the heart, and the brain. Its activities include drug discovery, biotechnology research, clinical development, and clinical trial management. Its operating segments are organized around NLRP3 inhibitor research and development programs for cardiovascular and neurologic diseases.

Webull offers Rezera Inc. stock information, including NASDAQ: RZRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RZRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RZRA stock methods without spending real money on the virtual paper trading platform.